Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berkman

Showing results (161-170 of 210) with videos related to

Pageof 21
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 1997
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogsM R Brzezinski, B J Spink, R A Dean, et al.
Angewandte Chemie (International Ed. in English)|September 8, 2011
Capture and visualization of hydrogen sulfide by a fluorescent probeChunrong Liu, Jia Pan, Sheng Li, et al.
Obstetrics and Gynecology|February 12, 2019
Noninvasive Prenatal Whole Genome Sequencing: Pregnant Women's Views and PreferencesHaley K Sullivan, Michelle Bayefsky, Paul G Wakim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's diseaseD P Schenkein, P Dixon, J F Desforges, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2026
Second generation PSMA-targeted turn-on probe for imaging cargo release in prostate cancer cellsNooshin Mesbahi, Brenna C McAllister, Hosog Yoon, et al.
The FEBS Journal|October 14, 2015
Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalitiesZora Novakova, Jiri Cerny, Cindy J Choy, et al.
Chemical Biology & Drug Design|June 19, 2013
Rationally designed sulfamides as glutamate carboxypeptidase II inhibitorsCindy J Choy, Melody D Fulton, Austen L Davis, et al.
Bioconjugate Chemistry|August 27, 2014
Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancerStacy E Martin, Tanushree Ganguly, Gerhard R Munske, et al.
Human Reproduction (Oxford, England)|November 26, 2020
Should germline genome editing be allowed? The effect of treatment characteristics on public acceptabilityI van Dijke, M van Wely, B E Berkman, et al.
Annals of Hematology|January 1, 1994
Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantationK B Miller, D P Schenkein, R Comenzo, et al.
Pageof 21

Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 6, 1997
Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogsM R Brzezinski, B J Spink, R A Dean, et al.
Angewandte Chemie (International Ed. in English)|September 8, 2011
Capture and visualization of hydrogen sulfide by a fluorescent probeChunrong Liu, Jia Pan, Sheng Li, et al.
Obstetrics and Gynecology|February 12, 2019
Noninvasive Prenatal Whole Genome Sequencing: Pregnant Women's Views and PreferencesHaley K Sullivan, Michelle Bayefsky, Paul G Wakim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's diseaseD P Schenkein, P Dixon, J F Desforges, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2026
Second generation PSMA-targeted turn-on probe for imaging cargo release in prostate cancer cellsNooshin Mesbahi, Brenna C McAllister, Hosog Yoon, et al.
The FEBS Journal|October 14, 2015
Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalitiesZora Novakova, Jiri Cerny, Cindy J Choy, et al.
Chemical Biology & Drug Design|June 19, 2013
Rationally designed sulfamides as glutamate carboxypeptidase II inhibitorsCindy J Choy, Melody D Fulton, Austen L Davis, et al.
Bioconjugate Chemistry|August 27, 2014
Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancerStacy E Martin, Tanushree Ganguly, Gerhard R Munske, et al.
Human Reproduction (Oxford, England)|November 26, 2020
Should germline genome editing be allowed? The effect of treatment characteristics on public acceptabilityI van Dijke, M van Wely, B E Berkman, et al.
Annals of Hematology|January 1, 1994
Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantationK B Miller, D P Schenkein, R Comenzo, et al.
Pageof 21